drugset / Trial / NCT04319471
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Phase 2
Unknown
70 enrolled
Fujian Cancer Hospital
Jiangxi Provincial Cancer Hospital · collabZhejiang Cancer Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a randomized, phase II, prospective, multicenter clinical trial to evaluate the efficacy and safety of sufficient chemoradiotherapy plus oral capecitabine/S-1 for 1 year in the treatment of oligometastatic Nasopharyngeal Carcinoma
Timeline
- Start
- 2020-06-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 2500 mg/m2 | Oral |
| Subject | S-1 | Small molecule | 40 mg | Oral |
| Subject | S-1 | Small molecule | 60 mg | Oral |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Background | nidaplatinum | Unknown | 80 mg/m2 | — |
| Background | nidaplatinum | Unknown | 100 mg/m2 | — |